Morimoto S - Search Results

1

A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis.

Morimoto S, Takahashi N, Someya K, Morita T, Jo F, Toyoda N, Kosaki A, Nishikawa M, Iwasaka T. Morimoto S, et al. Clin Exp Nephrol. 2010 Aug;14(4):363-6. doi: 10.1007/s10157-010-0271-6. Epub 2010 Feb 26. Clin Exp Nephrol. 2010. PMID: 20186457

2

Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.

Morimoto S, Yano Y, Maki K, Sawada K, Iwasaka T. Morimoto S, et al. Am J Nephrol. 2007;27(6):643-8. doi: 10.1159/000108634. Epub 2007 Sep 18. Am J Nephrol. 2007. PMID: 17878713 Clinical Trial.

3

Renal and vascular protective effects of cilnidipine in patients with essential hypertension.

Morimoto S, Yano Y, Maki K, Iwasaka T. Morimoto S, et al. J Hypertens. 2007 Oct;25(10):2178-83. doi: 10.1097/HJH.0b013e3282c2fa62. J Hypertens. 2007. PMID: 17885563 Clinical Trial.

4

Management of patients with recurrent nephrosis and intractable edema by intraperitoneal instillation of icodextrin solution.

Morimoto S, Takahashi N, Kikuchi S, Yamahara H, Imada T, Kohno K, Masaki H, Nishikawa M, Iwasaka T. Morimoto S, et al. Perit Dial Int. 2008 Sep-Oct;28(5):559-62. Perit Dial Int. 2008. PMID: 18708557 No abstract available.

5

Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.

Morimoto S, Maki K, Aota Y, Sakuma T, Iwasaka T. Morimoto S, et al. Hypertens Res. 2008 Aug;31(8):1603-10. doi: 10.1291/hypres.31.1603. Hypertens Res. 2008. PMID: 18971536 Clinical Trial.

6

Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.

Morimoto S, Jo F, Maki K, Iwasaka T. Morimoto S, et al. Clin Exp Hypertens. 2009 Feb;31(1):83-91. doi: 10.1080/10641960802627363. Clin Exp Hypertens. 2009. PMID: 19172462 Free article.

7

Prognostic significance of ankle-brachial index, brachial-ankle pulse wave velocity, flow-mediated dilation, and nitroglycerin-mediated dilation in end-stage renal disease.

Morimoto S, Yurugi T, Aota Y, Sakuma T, Jo F, Nishikawa M, Iwasaka T, Maki K. Morimoto S, et al. Am J Nephrol. 2009;30(1):55-63. doi: 10.1159/000201416. Epub 2009 Feb 10. Am J Nephrol. 2009. PMID: 19204388

8

Efficacy of clonidine in a patient with refractory hypertension and chronic renal failure exhibiting neurovascular compression of the rostral ventrolateral medulla.

Morimoto S, Aota Y, Sakuma T, Ichibangase A, Ikeda K, Sawada S, Iwasaka T. Morimoto S, et al. Hypertens Res. 2009 Mar;32(3):227-8. doi: 10.1038/hr.2009.1. Epub 2009 Feb 13. Hypertens Res. 2009. PMID: 19262487 No abstract available.

9

Risk factors of normal ankle-brachial index and low toe-brachial index in hemodialysis patients.

Morimoto S, Nakajima F, Yurugi T, Morita T, Jo F, Nishikawa M, Iwasaka T, Maki K. Morimoto S, et al. Ther Apher Dial. 2009 Apr;13(2):103-7. doi: 10.1111/j.1744-9987.2009.00663.x. Ther Apher Dial. 2009. PMID: 19379148

10

Thyroid hormone activation in vascular smooth muscle cells is negatively regulated by glucocorticoid.

Toyoda N, Yasuzawa-Amano S, Nomura E, Yamauchi A, Nishimura K, Ukita C, Morimoto S, Kosaki A, Iwasaka T, Harney JW, Larsen PR, Nishikawa M. Toyoda N, et al. Among authors: morimoto s. Thyroid. 2009 Jul;19(7):755-63. doi: 10.1089/thy.2009.0044. Thyroid. 2009. PMID: 19508118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,123 results

Search Page

Filters